Differences in performance of acute ischemic stroke artificial intelligence platforms.

Autor: Ezzeldin M; Department of Clinical Sciences, College of Medicine, University of Houston, Houston, Texas, USA mohamadezzeldin@hotmail.com.; Neuroendovascular Surgery, HCA Houston, Houston, Texas, USA., Delora A; Emergency Medicine, HCA Houston, Kingwood, Texas, USA., Hassan AE; Department of Neurology, University of Texas Rio Grande Valley, Harlingen, Texas, USA., Ezzeldin R; Medicine, Jordan University of Science and Technology Faculty of Medicine, Irbid, Jordan., Hadjialiakbari C; Emergency Medicine, HCA Houston, Kingwood, Texas, USA., Percenti E; Internal Medicine, HCA Houston, Kingwood, Texas, USA., Torres J; Internal Medicine, HCA Houston, Kingwood, Texas, USA., Alderazi YJ; Cerebrovascular Disease and Neurointerventional Surgery, HCA Gulf Coast Division, Webster, Texas, USA.
Jazyk: angličtina
Zdroj: Journal of neurointerventional surgery [J Neurointerv Surg] 2024 Sep 04. Date of Electronic Publication: 2024 Sep 04.
DOI: 10.1136/jnis-2024-022373
Abstrakt: Competing Interests: Competing interests: HCA Healthcare has a minority equity stake in VIZ.ai and also purchases products from the company for use in its facilities. AEH is a consultant and a speaker for Viz.ai, who developed the Viz LVO algorithm that we tested, and he is also involved in a study sponsored by Viz.ai (LVO Synchronise Study) looking at the impact of Viz LVO implementation on patient timing and outcomes. ME is a speaker/consultant for Viz AI and Imperative Care and has investments in Galaxy Therapeutics. In the interest of full disclosure, below is a list of conflicts of related companies that are in a related field that we do not believe directly impacted this study. YJA has stock in Sanavention. AEH is a consultant/speaker for Medtronic, Microvention, Stryker, Penumbra, Cerenovus, Genentech, GE Healthcare, Scientia, Balt, Viz.ai, Insera therapeutics, Proximie, NeuroVasc, NovaSignal, Vesalio, Rapid Medical, Imperative Care, and Galaxy Therapeutics. AEH is a principal investigator of COMPLETE study (Penumbra), LVO SYNCHRONISE (Viz.ai), Millipede Stroke Trial (Perfuze), and RESCUE ICAD (Medtronic). AEH is on the steering committee/publication committee of SELECT, DAWN, SELECT 2, EXPEDITE II, EMBOLISE, CLEAR, ENVI, DELPHI, and DISTALS. AEH is DSMB of the COMAND trial.
Databáze: MEDLINE